Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
APT MedicalSHSE:688617 -1.35%78 Days Payable is 23.67 as of Jun. 2026, which is 17% below its 10-year median of 28.41. GuruFocus rates SHSE:688617 with a GF Score™ of 78/100 and a GF Value™ of ¥366.17 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 795 Medical Devices & Instruments companies, APT Medical ranks worse than 86.42% on this metric.
The historical rank and industry rank for APT Medical's Days Payable or its related term are showing as below:
SHSE:688617'
s Days Payable Range Over the Past 10 Years
Min: 21.33 Med: 28.41 Max: 46.19
Current: 28.71
During the past 9 years, APT Medical's highest Days Payable was 46.19. The lowest was 21.33. And the median was 28.41.
SHSE:688617's Days Payable is ranked worse than 86.42% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.41
vs SHSE:688617: 28.71
APT Medical's Days Payable
declined
from Jun. 2025 (36.21) to Jun. 2026 (23.67).
It may suggest that APT Medicalaccelerated paying its suppliers.
The historical data trend for APT Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688617 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, APT Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
APT Medical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, APT Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where APT Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
APT Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
APT Medical (SHSE:688617) has a Days Payable of 23.67 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on APT Medical and its competitors. This is 17% below median its historical median of 28.41. Over the past decade, APT Medical's Days Payable has ranged from 21.33 to 46.19. According to the industry distribution chart, APT Medical ranks #687 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 86.4%.
Is APT Medical's Days Payable too high?
APT Medical's current Days Payable of 23.67 is 17% below median its 10-year median of 28.41. Over the past 10 years, this metric has ranged from a low of 21.33 to a high of 46.19. The Medical Devices & Instruments industry median Days Payable is 68.41. APT Medical's value of 23.67 is 65.4% below this industry median. Based on the distribution chart, APT Medical ranks #687 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, APT Medical has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does APT Medical's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, APT Medical ranks #687 out of 795 companies for Days Payable. This places APT Medical in the lower half of its industry. The industry median Days Payable is 68.41. APT Medical's value of 23.67 is 65.4% below this benchmark. Historically, APT Medical's own Days Payable has ranged from 21.33 to 46.19 over the past decade. While the company's 10-year median is 28.41 vs. the industry median of 68.41, APT Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.41, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. APT Medical's current Days Payable of 23.67 is 65.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on APT Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. APT Medical's current Days Payable is 23.67, which is 17% below median its own 10-year median of 28.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is APT Medical stock overvalued right now?
Based on GuruFocus' analysis, APT Medical (SHSE:688617) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥366.17, compared to a current price of ¥239.60 — trading 34.6% below its estimated fair value. The current Days Payable is 23.67, which is 17% below median its 10-year median of 28.41 and 65.4% below the Medical Devices & Instruments industry median of 68.41. APT Medical's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For APT Medical (SHSE:688617), the current Days Payable is 23.67 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is APT Medical (SHSE:688617) Overvalued in 2026?
Based on GuruFocus' analysis, APT Medical stock appears to be undervalued.
The current stock price of ¥239.60 is trading 34.6% below its estimated GF Value™ of ¥366.17.
GuruFocus considers APT Medical to be Significantly Undervalued.
Key valuation signals for SHSE:688617:
Days Payable: 23.67 (17% below median its 10-year median of 28.41)
GF Value™: ¥366.17 vs. price of ¥239.60 (34.6% below fair value)
Industry Position: 65.4% below the Medical Devices & Instruments median (#687 of 795)
No single metric tells the full story. See the SHSE:688617 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
78GF Score
Get the complete analysis for SHSE:688617
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688617 has been successfully added to your 
